Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Protara Therapeutics Inc. | -6.630% | -4.450% | -12.479% | 22.529% | -6.592% | 54.296% | -66.130% |
| India Globalization Capital | 5.000% | 12.500% | 3.279% | 11.504% | 5.882% | -8.029% | -82.328% |
| Gensight Biologics SA | -3.620% | -4.398% | -7.606% | -64.320% | -27.160% | -96.587% | -98.885% |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat